What is TRDA's market capitalization?

Entrada Therapeutics Inc has a market capitalization of $503.44M.

Does TRDA pay a dividend?

Entrada Therapeutics Inc does not currently pay a dividend, or dividend data is unavailable. Many growth-oriented companies reinvest profits rather than paying dividends.

What is TRDA's earnings per share (EPS)?

Entrada Therapeutics Inc's trailing twelve-month earnings per share (EPS) is -$3.47. EPS measures the portion of company profit allocated to each outstanding share of stock.

TRDA

NASDAQ

Entrada Therapeutics Inc

Price unavailable — configure POLYGON_API_KEY

Overview Earnings Dividends

Key Statistics

Market Cap$503.44M

P/E RatioN/A

Div. Yield—

EPS (TTM)-$3.47

52W High$13.66

52W Low$4.93

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

Employees152

Price Performance

1 Week+11.72%

3 Month+25.24%

1 Year+65.62%

FinancialsAnnual · QuiverQuant

Revenue$129.01M

Assets$469.19M

Liabilities$226.83M

Net Income$6.68M loss

About

Entrada Therapeutics Inc. (TRDA) is a pioneering biotechnology firm committed to developing transformative therapies for severe diseases with considerable unmet medical needs. Leveraging its proprietary Therapeutics for RNA Delivery (TRADA) platform, the company targets RNA and protein dysfunctions associated with debilitating conditions such as muscular dystrophies and genetic disorders. With a robust clinical pipeline and an emphasis on scientific rigor, Entrada is strategically positioned to advance therapeutic solutions that seek to enhance patient outcomes, supported by a seasoned leadership team focused on innovation in the biopharmaceutical landscape.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account

Analyze TRDA with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.